Lexicon Pharmaceuticals, Inc.
LXRX
Jodie situation report
Lexicon Pharmaceuticals, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 5 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.
- LXRX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if LXRX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind LXRX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
VTRSViatris Inc.supplierMar 5, 2026 ▾
“Lexicon and Viatris have entered into a manufacturing and supply agreement pursuant to which Lexicon will supply the development and commercial requirements of sotagliflozin of Viatris, and Viatris will pay an agreed upon transfer price for such supply.”
VTRSViatris Inc.partnerMar 5, 2026 ▾
“The Company further evaluated its stated intent in the Viatris Licensing Agreement to enter into a separate manufacturing and supply agreement related to supply of the licensed products to Viatris.”
Depended on by
EWTXEdgewise Therapeutics, Inc.competitorMay 7, 2026 ▾
“In the field of emerging treatments for HCM, competitors include Bristol-Myers Squibb (BMS), Cytokinetics, Imbria Pharmaceuticals, Lexicon Pharmaceuticals, and Celltrion, and Braveheart Bio.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
LXRX is currently a Early Follower in the organic co-movement group Biotech Oncology & Energy. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for LXRX; it is not active in the latest market snapshot.